Guest
Guest
Jul 03, 2023
8:13 AM
|
Clinical Diagnostics Company play a significant role in advancing precision oncology, which aims to tailor cancer treatment based on individual characteristics. They contribute in the following ways:
Molecular Profiling: Clinical diagnostics companies develop and provide tests that analyze genetic mutations, gene expression patterns, and other molecular markers in tumor samples. This information helps oncologists identify specific molecular targets and select targeted therapies that are most likely to be effective for individual patients.
Companion Diagnostics: These companies develop companion diagnostic tests that are designed to identify patients who are most likely to benefit from a specific targeted therapy. Companion diagnostics help ensure that patients receive the most appropriate treatment, maximizing therapeutic efficacy and minimizing adverse effects.
Monitoring Treatment Response: Clinical diagnostics companies also offer tests to monitor treatment response and detect minimal residual disease. These tests allow oncologists to assess the effectiveness of treatment over time, make adjustments if necessary, and provide personalized patient care throughout the cancer journey.
|
